• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对一种HIV-1逆转录酶的RNA假结抑制剂进行全面的化学修饰干扰和核苷酸取代分析。

Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase.

作者信息

Green L, Waugh S, Binkley J P, Hostomska Z, Hostomsky Z, Tuerk C

机构信息

NeXagen, Inc., Boulder, CO 80301.

出版信息

J Mol Biol. 1995 Mar 17;247(1):60-8. doi: 10.1006/jmbi.1994.0122.

DOI:10.1006/jmbi.1994.0122
PMID:7534830
Abstract

We had previously used in vitro RNA selection techniques to describe a consensus RNA pseudoknot that binds and inhibits HIV-1 reverse transcriptase (HIV-RT). In this work we constructed variants of this consensus pseudoknot in order to evaluate the contributions of individual nucleotide identities and secondary structure to affinity for HIV-RT. We have also used chemical modification of ligand RNAs to corroborate the predicted structure of the pseudoknot, to discover which modifiable groups are protected from chemical attack when bound to HIV-RT, and to find which modifications interfere with binding to HIV-RT. A novel interference study is presented which involves selection of ligands from a pool created by mixed reagent oligonucleotide synthesis in order to rapidly determine allowed substitutions of 2'-OCH3 groups for the usual 2'-OH group in such RNA ligands.

摘要

我们之前使用体外RNA筛选技术描述了一种能结合并抑制HIV-1逆转录酶(HIV-RT)的共有RNA假结。在这项工作中,我们构建了这种共有假结的变体,以评估单个核苷酸序列和二级结构对与HIV-RT亲和力的贡献。我们还对配体RNA进行化学修饰,以证实假结的预测结构,发现哪些可修饰基团在与HIV-RT结合时免受化学攻击,并找出哪些修饰会干扰与HIV-RT的结合。本文提出了一项新颖的干扰研究,该研究涉及从混合试剂寡核苷酸合成产生的文库中筛选配体,以便快速确定此类RNA配体中通常的2'-OH基团被2'-OCH3基团取代的允许情况。

相似文献

1
Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase.对一种HIV-1逆转录酶的RNA假结抑制剂进行全面的化学修饰干扰和核苷酸取代分析。
J Mol Biol. 1995 Mar 17;247(1):60-8. doi: 10.1006/jmbi.1994.0122.
2
Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase.弯曲假结与1型人类免疫缺陷病毒(HIV-1)逆转录酶的新型RNA抑制剂。
J Mol Biol. 1996 Dec 13;264(4):650-66. doi: 10.1006/jmbi.1996.0667.
3
Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.来自猫免疫缺陷病毒的逆转录酶的抑制性RNA配体。
Biochemistry. 1996 May 28;35(21):6923-30. doi: 10.1021/bi9600106.
4
Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.通过荧光光谱法评估1型人类免疫缺陷病毒逆转录酶与引物tRNA的结合:特异性及与引物/模板结合的比较
Biochemistry. 1996 Apr 9;35(14):4609-18. doi: 10.1021/bi9526387.
5
Effect of RNA secondary structure on RNA cleavage catalyzed by HIV-1 reverse transcriptase.RNA二级结构对HIV-1逆转录酶催化的RNA切割的影响。
Biochemistry. 1997 Oct 14;36(41):12468-76. doi: 10.1021/bi971218+.
6
Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase.RNA二级结构对HIV-1逆转录酶催化的DNA合成动力学的影响。
Biochemistry. 1997 Oct 14;36(41):12459-67. doi: 10.1021/bi971217h.
7
All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: a 3D QSAR approach.与抑制剂复合的HIV-1逆转录酶非核苷结合位点的全原子模型:一种3D QSAR方法。
J Med Chem. 1996 Apr 12;39(8):1645-50. doi: 10.1021/jm9508088.
8
Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.1型人类免疫缺陷病毒逆转录酶与莫洛尼鼠白血病病毒逆转录酶核糖核酸酶H活性的异同
J Mol Biol. 1999 Dec 17;294(5):1097-113. doi: 10.1006/jmbi.1999.3325.
9
Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.莫洛尼鼠白血病病毒逆转录酶N端片段与核酸复合的晶体结构:模板引物与指状结构域结合的功能意义
J Mol Biol. 2000 Feb 18;296(2):613-32. doi: 10.1006/jmbi.1999.3477.
10
A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).人类免疫缺陷病毒1型逆转录酶中的单个保守氨基酸取代赋予了对(+)-(5S)-4,5,6,7-四氢-5-甲基-6-(3-甲基-2-丁烯基)咪唑并[4,5,1-jk][1,4]苯并二氮杂卓-2(1H)-硫酮(TIBO R82150)的抗性。
Mol Pharmacol. 1993 Jan;43(1):11-6.

引用本文的文献

1
Enhanced SELEX Platforms for Aptamer Selection with Improved Characteristics: A Review.用于筛选具有改进特性适配体的增强型SELEX平台综述
Mol Biotechnol. 2024 Aug 16. doi: 10.1007/s12033-024-01256-w.
2
Binding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase.与 HIV-1 逆转录酶结合的界面及对其切割的影响。
Nucleic Acids Res. 2020 Mar 18;48(5):2709-2722. doi: 10.1093/nar/gkz1224.
3
Poly-Target Selection Identifies Broad-Spectrum RNA Aptamers.多靶点选择鉴定出广谱RNA适配体。
Mol Ther Nucleic Acids. 2018 Dec 7;13:605-619. doi: 10.1016/j.omtn.2018.10.010. Epub 2018 Oct 24.
4
Aptamers against pathogenic microorganisms.抗病原微生物的适配体。
Crit Rev Microbiol. 2016 Nov;42(6):847-65. doi: 10.3109/1040841X.2015.1070115. Epub 2015 Aug 10.
5
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents.具有类蛋白侧链的核酸配体:修饰的适体及其作为诊断和治疗剂的用途。
Mol Ther Nucleic Acids. 2014 Oct 7;3(10):e201. doi: 10.1038/mtna.2014.49.
6
Inhibition of the foot-and-mouth disease virus subgenomic replicon by RNA aptamers.RNA适体对口蹄疫病毒亚基因组复制子的抑制作用
J Gen Virol. 2014 Dec;95(Pt 12):2649-2657. doi: 10.1099/vir.0.067751-0. Epub 2014 Aug 5.
7
Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, "UCAA-motif" RNA Aptamers.非假结“UCAA 基序”RNA 适体对 HIV-1 逆转录酶和复制的强效抑制作用。
Mol Ther Nucleic Acids. 2013 Feb 5;2(2):e71. doi: 10.1038/mtna.2012.62.
8
Techniques for molecular imaging probe design.分子影像探针设计技术。
Mol Imaging. 2011 Dec;10(6):407-19.
9
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.使用计算结构建模合理截短针对前列腺特异性膜抗原的 RNA 适体。
Nucleic Acid Ther. 2011 Oct;21(5):299-314. doi: 10.1089/nat.2011.0313.
10
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.通过微流控选择和高通量测序进行 DNA 适体的定量选择。
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15373-8. doi: 10.1073/pnas.1009331107. Epub 2010 Aug 12.